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INCIDENTAL EOSINOPHILIA
Always take a travel history in eosinophilia
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We emphasise the need to take a travel history from all patients
with eosinophilia and to clarify the appropriate investigations
for parasitic infections, the most common cause of eosinophilia
worldwide.1 Delay in taking a travel history can have serious
consequences, such as failure to diagnose and treat
asymptomatic strongyloidiasis before immunosuppressive
therapy is given.2 However, travel histories are obtained from
less than 20% of British adults with acute clinical syndromes
that might be travel related.3
Eosinophilia is typically caused by helminths, not giardiasis or
most other protozoal infections. Examination of the famous
“hot stool” for ova, cysts, and parasites is only needed when
amoebic dysentery is suspected, in which case faeces, mucus,
or rectal scrapings should be examined immediately for motile
trophozoites of Entamoeba histolytica with ingested
erythrocytes. Amoebiasis is not usually associated with
eosinophilia, although this is a common misconception.4
For other parasites, the examination of fresh or preserved faecal
specimens is not quite so urgent, and the choice of other
investigations, including serological screening, depends on
many factors. Strongyloidiasis is ubiquitous in the tropics, but
eosinophilia in travellers or immigrants from Africa is more
likely to be caused by schistosomiasis or loiasis. Comprehensive
British guidelines on the diagnosis and management of travel
related eosinophilia have recently been published.5
We recommend the automatic generation of reminders in
laboratory reports on full blood counts with raised eosinophils,
along the lines of, “Note the presence of eosinophilia. Have you
taken a travel and drug exposure history?” These could be added
to the learning points tabled by Sims and Erber.1
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